__NUXT_JSONP__("/drugs/Flanvotumab", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"1188277-05-5",chebiId:b,chemicalFormula:b,definition:"A monoclonal antibody directed against the melanosomal membrane protein gp75 (or Tyrosinase-Related Protein 1 (TRP1)) with potential immunostimulatory and antineoplastic activities. Anti-gp75 monoclonal antibody IMC-20D7S targets and binds to gp75. This may lead to the induction of cytotoxic T cell immune and antibody-mediated immune responses against melanoma cells expressing gp75. gp75, a pigmentation-associated antigen, is expressed in melanosomes of human melanocytes and melanomas.",fdaUniiCode:"ZNV4738BS6",identifier:"C91384",preferredName:a,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C129822","C20401"],synonyms:["Anti-gp75 Monoclonal Antibody IMC-20D7S","FLANVOTUMAB",a,"IMC-20D7S","IMC20D7S"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FFlanvotumab",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Flanvotumab","","2021-10-30T13:47:23.093Z")));